Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Clemens Krepler, Min Xiao, Minu Samanta, Adina Vultur, Hsin-Yi Chen, Patricia Brafford, Patricia I. Reyes-Uribe, Molly Halloran, Thomas Chen, Xu He, Denitsa Hristova, Qin Liu, Ahmed A. Samatar, Michael A. Davies, Katherine L. Nathanson, Mizuho Fukunaga-Kalabis, Meenhard Herlyn, Jessie Villanueva
Published Sep 16, 2016 · Vol. 7, No. 44 · pp. 71211-71222
Lukas Goertz, Stefan Werner Schneider, Anna Desch, Frank Thomas Mayer, Julian Koett, Kai Nowak, Ioannis Karampinis, Michael K. Bohlmann, Viktor Umansky, Alexander Thomas Bauer
Published Sep 2, 2016 · Vol. 7, No. 42 · pp. 68527-68545
Joohyun Lee, Kyung Eun Kim, Soyoung Cheon, Ju Han Song, Younkyung Houh, Tae Sung Kim, Minchan Gil, Kyung Jin Lee, Seonghan Kim, Daejin Kim, Dae Young Hur, Yoolhee Yang, Sa Ik Bang, Hyun Jeong Park, Daeho Cho
Published Aug 29, 2016 · Vol. 7, No. 40 · pp. 65825-65836